Direkt zum Inhalt
Merck

Selectivity of diadenosine polyphosphates for rat P2X receptor subunits.

European journal of pharmacology (1999-03-19)
S S Wildman, S G Brown, B F King, G Burnstock
ZUSAMMENFASSUNG

The pharmacological activity of diadenosine polyphosphates was investigated at three recombinant P2X receptors (rat P2X1, rat P2X3, rat P2X4) expressed in Xenopus oocytes and studied under voltage-clamp conditions. For the rat P2X1 receptor, only P1,P6-diadenosine hexaphosphate (Ap6A) was a full agonist yet 2-3 folds less potent than ATP. At rat P2X3, P1,p4-diadenosine tetraphosphate (Ap4A), P1,P5-diadenosine pentaphosphate (Ap5A) and Ap6A were full agonists and more potent than ATP. Ap4A alone was equipotent with ATP at rat P2X4, but only as a partial agonist. Compared to known data for rat P2X2 and human P2X1 receptors, our findings contrast with rat P2X2 where only Ap4A is a full agonist although four folds less potent than ATP. At rat and human orthologues of P2X1, Ap5A was a partial agonist with similar potency. These data provide a useful basis for selective agonists of P2X receptor subunits.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
P1,P4-Di(adenosine-5′) tetraphosphate ammonium salt, ≥95% (HPLC), powder